Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

Alan P. Venook, Charles Blanke, Donna Niedzwiecki, Heinz Josef Lenz, John R. Taylor, Donna R. Hollis, Susan Sutherland, Richard M. Goldberg

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)536-538
Number of pages3
JournalClinical Colorectal Cancer
Volume6
Issue number7
DOIs
StatePublished - 2007

Fingerprint

Biological Factors
Leukemia
Adenocarcinoma
Drug Therapy
Neoplasms
Cetuximab
Bevacizumab

Keywords

  • Bevacizumab
  • Cetuximab
  • FOLFIRI
  • FOLFOX

ASJC Scopus subject areas

  • Oncology

Cite this

Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial : A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. / Venook, Alan P.; Blanke, Charles; Niedzwiecki, Donna; Lenz, Heinz Josef; Taylor, John R.; Hollis, Donna R.; Sutherland, Susan; Goldberg, Richard M.

In: Clinical Colorectal Cancer, Vol. 6, No. 7, 2007, p. 536-538.

Research output: Contribution to journalArticle

Venook, Alan P. ; Blanke, Charles ; Niedzwiecki, Donna ; Lenz, Heinz Josef ; Taylor, John R. ; Hollis, Donna R. ; Sutherland, Susan ; Goldberg, Richard M. / Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial : A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. In: Clinical Colorectal Cancer. 2007 ; Vol. 6, No. 7. pp. 536-538.
@article{e78f8c5a6eb3424eb0649cd4f69dfed5,
title = "Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma",
keywords = "Bevacizumab, Cetuximab, FOLFIRI, FOLFOX",
author = "Venook, {Alan P.} and Charles Blanke and Donna Niedzwiecki and Lenz, {Heinz Josef} and Taylor, {John R.} and Hollis, {Donna R.} and Susan Sutherland and Goldberg, {Richard M.}",
year = "2007",
doi = "10.3816/CCC.2007.n.021",
language = "English (US)",
volume = "6",
pages = "536--538",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial

T2 - A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

AU - Venook, Alan P.

AU - Blanke, Charles

AU - Niedzwiecki, Donna

AU - Lenz, Heinz Josef

AU - Taylor, John R.

AU - Hollis, Donna R.

AU - Sutherland, Susan

AU - Goldberg, Richard M.

PY - 2007

Y1 - 2007

KW - Bevacizumab

KW - Cetuximab

KW - FOLFIRI

KW - FOLFOX

UR - http://www.scopus.com/inward/record.url?scp=34250330400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250330400&partnerID=8YFLogxK

U2 - 10.3816/CCC.2007.n.021

DO - 10.3816/CCC.2007.n.021

M3 - Article

C2 - 17553204

AN - SCOPUS:34250330400

VL - 6

SP - 536

EP - 538

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 7

ER -